重新审视口咽癌的喂养管使用:6年前瞻性登记分析
该研究基于2015至2021年前瞻性队列的回顾性分析,纳入924例口咽癌患者,评估胃造瘘管(G管)使用情况。结果显示27%患者接受G管,较10年前本机构下降50%;放化疗增加G管风险(OR 2.78),经口机器人手术(TORS)和基线吞咽功能保留降低风险。
要点
- 现代口咽癌队列中G管使用率为27%,较10年前本机构下降50%。
- 放化疗与G管风险升高相关(OR 2.78 [1.87-4.22]),TORS与风险降低相关(OR 0.31 [0.15-0.57])。
- 基线PSSHN饮食评分≥60与G管风险降低(OR 0.26 [0.15-0.45])及拔管概率升高(HR 1.65 [1.03-2.66])相关。
核心结论
- 在现代口咽癌治疗队列中,27%患者接受G管,较10年前本机构下降50%。
- 基线吞咽功能保留和/或适合TORS的患者可能具有更低的G管风险和更短的带管时间。
研究设计与样本
- 研究设计为对2015至2021年前瞻性队列的回顾性分析。
- 研究在单一机构NCI指定综合癌症中心进行,经IRB批准纳入新发口咽鳞癌或原发不明伴颈转移患者,共924例。
- 基线吞咽功能通过视频荧光透视和头颈癌功能状态量表(PSSHN)评估。
主要发现
- 924例患者中,多数为I至II期(81%)、p16阳性(89%)、淋巴结阳性(88%)疾病,中位随访2.6年(四分位距1.5-3.9)。
- 91%患者接受放疗/放化疗,16%接受TORS;G管使用率为27%(TORS后为5%)。
- G管风险随放化疗升高(OR 2.78 [1.87-4.22]),随TORS降低(OR 0.31 [0.15-0.57]),随PSSHN饮食评分≥60降低(OR 0.26 [0.15-0.45])。
- G管拔除概率随时间在T3至T4肿瘤中较低(HR 0.52 [0.38-0.71]),在PSSHN饮食评分≥60中较高(HR 1.65 [1.03-2.66])。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients treated for oropharyngeal cancer (OPC) have historically demonstrated high feeding tube rates for decreased oral intake and malnutrition. We re-examined feeding tube practices in these patients. STUDY DESIGN: Retrospective analysis of prospective cohort from 2015 to 2021. SETTING: Single-institution NCI-Designated Comprehensive Cancer Center. METHODS: With IRB approval, patients with new oropharyngeal squamous cell cancer or (unknown primary with neck metastasis) were enrolled. Baseline swallowing was assessed via videofluoroscopy and Performance Status Scale for Head and Neck Cancer (PSSHN). G-tubes or nasogastric tubes (NGT) were placed for weight loss before, during, or after treatment. Prophylactic NGT were placed during transoral robotic surgery (TORS). Tube duration was censored at last disease-free follow-up. Multivariate regression was performed for G-tube placement (odds ratio [OR] [95% confidence interval [CI]) and removal (Cox hazard ratio, hazard ratio [HR] [95% CI]). RESULTS: Of 924 patients, most had stage I to II (81%), p16+ (89%), node-positive (88%) disease. Median follow-up was 2.6 years (interquartile range 1.5-3.9). Most (91%) received radiation/chemoradiation, and 16% received TORS. G-tube rate was 27% (5% after TORS). G-tube risk was increased with chemoradiation (OR 2.78 [1.87-4.22]) and decreased with TORS (OR 0.31 [0.15-0.57]) and PSSHN-Diet score ≥60 (OR 0.26 [0.15-0.45]). G-tube removal probability over time was lower for T3 to T4 tumors (HR 0.52 [0.38-0.71]) and higher for PSSHN-Diet score ≥60 (HR 1.65 [1.03-2.66]). CONCLUSIONS: In this modern cohort of patients treated for OPC, 27% received G-tubes-50% less than institutional rates 10 years ago. Patients with preserved baseline swallowing and/or those eligible for TORS may have lower G-tube risk and duration.
引用
- Anderson BJ, Moreno AC, Qing Y, et al. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis. Otolaryngol Head Neck Surg. 2024. PMID: 38353360. doi:10.1002/ohn.672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。